Open AccessDiffusion-weighted MRI, 11C-choline PET and 18F-fluorodeoxyglucose PET for predicting the Gleason score in prostate carcinoma
Author(s) -
Joe H. Chang,
Daryl Lim Joon,
Sze Ting Lee,
CheeYan Hiew,
Stephen Esler,
Sylvia Gong,
Morikatsu Wada,
David Clouston,
Richard O’Sullivan,
Yin Peng Goh,
Henri TochonDanguy,
J. Gordon Chan,
Damien Bolton,
Andrew M. Scott,
Vincent Khoo,
Ian D. Davis
Publication year - 2013
Publication title -
european radiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.606
H-Index - 149
eISSN - 1432-1084
pISSN - 0938-7994
DOI - 10.1007/s00330-013-3045-1
Subject(s) - medicine , prostatectomy , prostate cancer , biopsy , magnetic resonance imaging , positron emission tomography , ultrasound , radiology , nuclear medicine , prostate , neuroradiology , fluorodeoxyglucose , urology , cancer , neurology , psychiatry
To evaluate the accuracy of transrectal ultrasound-guided (TRUS) biopsy, diffusion-weighted (DW) magnetic resonance imaging (MRI), (11)C-choline (CHOL) positron emission tomography (PET), and (18)F-fluorodeoxyglucose (FDG) PET in predicting the prostatectomy Gleason risk (GR).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom